Volume 98, Issue 5 pp. 360-363

Case report A reversible neuronal antibody (anti-Tr) associated paraneoplastic cerebellar degeneration in Hodgkin's disease

J. Peltola

Corresponding Author

J. Peltola

Departments of Neurology, Tampere University Hospital, Tampere, Finland

Departments of Medical School, University of Tampere, Finland

J Peltola. University of Tampere, Medical School, Department of Neurology, P.O. Box 607 FIN-33101 Tampere, FinlandSearch for more papers by this author
A. Hietaharju

A. Hietaharju

Departments of Neurology, Tampere University Hospital, Tampere, Finland

Search for more papers by this author
I. Rantala

I. Rantala

Departments of Pathology, Tampere University Hospital, Tampere, Finland

Search for more papers by this author
T. Lehtinen

T. Lehtinen

Departments of Oncology, Tampere University Hospital, Tampere, Finland

Search for more papers by this author
H. Haapasalo

H. Haapasalo

Departments of Pathology, Tampere University Hospital, Tampere, Finland

Search for more papers by this author
First published: 29 January 2009
Citations: 30

Abstract

Paraneoplastic cerebellar degeneration (PCD) has been associated with a variety of neoplasms, most commonly with gynecologic tumors, breast cancer, small cell lung cancer, and Hodgkin's disease (HD). In some patients PCD is associated with circulating antineuronal antibodies like anti-Hu, anti-Yo or anti-Ri. Previously, only 5 patients with a new antineuronal antibody called anti-Tr, proposed to be specific for HD, have been reported. We describe 1 further patient with HD and reversible PCD with a decline in anti-Tr antibody titers in cerebrospinal fluid and serum corresponding to the improvement of clinical symptoms. At the present time the immunoreactive pattern observed in rat cerebellum is the only way to identify anti-Tr antibodies and differentiate them from other antibodies that immunoreact with the Purkinje cells.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.